RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R10785 | Savolitinib (Volitinib; HMPL-504; AZD-6094) | Savolitinib(Volitinib; AZD-6094; Volitinib) is an orally bioavailable inhibitor |
| R10818 | Varlitinib; ARRY 543 | Varlitinib is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with |
| R10837 | INCB28060 | Capmatinib (INCB28060) is a novel, ATP-competitive inhibitor of c-MET with IC50 |
| R10880 | Lapatinib (GW572016; GW2016) | Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 |
| R10867 | LDC1267 | LDC1267 is a highly selective TAM kinase inhibitor with IC50 of <5 nM, 8 nM, |
| R10881 | Sorafenib (Synonyms: Bay 43-9006) | Sorafenib (Bay 43-9006) is a potent, orally active multikinase inhibitor with IC |
| R10882 | Sunitinib (Synonyms: SU 11248) | Sunitinib Malate is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and |
| R10891 | Vatalanib | Vatalanib (PTK787) 2HCl is an inhibitor of VEGFR2/KDR with IC50 of 37 nM in a ce |
| R10898 | Lorlatinib (Synonyms: PF-06463922) | PF-06463922 is a potent, dual ALK/ROS1 inhibitor with Ki of <0.02 nM, <0.0 |
| R10900 | CL-387785 ; EKI-785 | CL-387785(EKI785; WAY-EKI 785) is an irreversible inhibitor of EGFR with IC50 of |
| R10904 | Irbinitinib; ARRY-380; ONT-380 | Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor with IC5 |
| R10930 | Icotinib | Icotinib is a potent and specific EGFR inhibitor with IC50 of 5 nM, including th |
| R10941 | Alectinib(CH5424802; RO5424802; AF802) | Alectinib (CH5424802) is a potent ALK inhibitor with IC50 of 1.9 nM in cell-free |
| R11470 | Apatinib methanesulfonate | Apatinib is an orally bioavailable, selective VEGFR2 inhibitor with IC50 of 1 nM |
| R11479 | Lapatinib ditosylate;GW572016 ditosylate; GW2016 ditosylate | Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 |
| R11514 | Pazopanib (Synonyms: GW786034) | Pazopanib is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FG |
| R11523 | BMS-794833 | BMS-794833 is a potent ATP competitive inhibitor of Met/VEGFR2 with IC50 of 1.7 |
| R11536 | PD168393 | PD168393 is an irreversible EGFR inhibitor with IC50 of 0.70 nM, irreversibly al |
| R11550 | Dovitinib | Dovitinib (TKI258) Lactate is the Lactate of Dovitinib, which is a multitargeted |
| R11552 | BFH-772 | BFH772 is a novel potent oral VEGFR2 inhibitor, targeting VEGFR2 kinase with IC5 |
| R11557 | CH5183284; Debio 1347 | CH5183284 is a selective and orally available FGFR inhibitor with IC50 of 9.3 nM |
| R11600 | Bemcentinib (Synonyms: R428; BGB324) | R428 (BGB324) is an inhibitor of Axl with IC50 of 14 nM, >100-fold selective |
| R11603 | WZ3146 | WZ3146 is a mutant-selective irreversible inhibitor of EGFR(L858R) and |
| R190306 | AST2818 mesylate | AST2818 mesylate is an EGFR inhibitor. |
| R2032681 | BMS599626 | BMS-599626 (AC480) is a selective and orally bioavailable HER1 and HER2 inhibito |
